Skip to main content
Signal8

PERRIGO Co plc (PRGO)

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Sector: Pharmaceutical Preparations

Industry: Drug Manufacturers - Specialty & Generic

Perrigo Company plc logo

Perrigo Company plc

NYSE:PRGOHealthcare
-0.88%$15.82
AH Close$15.82+0.00%vs close
Mkt Cap$2.2B
Float137.73M
O/S138.77M
Inst Own-
SI17.6%
Div Yield7.33%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$2.20B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 138.77M shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNYSE
CountryIEIE
IPO DateDec 17, 1991
Shares Outstanding138.77M
Float137.73M
Company Overview

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments.

It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products.

It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands.

The company also offers contract manufacturing services.

It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies.

The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Leadership

Patrick Lockwood-Taylor

President & CEO; President & Chief Executive Officer

Abbie Lennox

Executive Vice President & Chief Scientific Officer

Eduardo Guarita Bezerra

Executive Vice President & Chief Financial Officer

Charles Atkinson

Executive Vice President, General Counsel & Secretary

Independent: 3 of 4 listed

Employees

8K+

Country

IE

Sector

Healthcare

Website

perrigo.com

Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
No price targets available
Ratings Distribution
BUY
14
HOLD
21
SELL
1
TOTAL36
Insider Trades
InsiderTypeShares
Parker Geoffrey M. profile photoParker Geoffrey M.Automatic Sell607
Parker Geoffrey M. profile photoParker Geoffrey M.Option Exercise1.3K
Alford Bradley A profile photoAlford Bradley AOption Exercise1.3K
Alford Bradley A profile photoAlford Bradley AAutomatic Sell607
Parker Geoffrey M. profile photoParker Geoffrey M.Option Exercise1.3K
Alford Bradley A profile photoAlford Bradley AOption Exercise1.3K
Shareholders
-
Institutionalⓘ
(343)
0.4%
Insiderⓘ
(21)
0.0%
5%+ Owners
(0)
-
Unattributed (incl. retail)ⓘ
Insider0.4%
Sources: 13F, Form 4, 13D/13GO/S: 138.8M · as of 31 Jul 2026 · SEC cover page
Insiders & Institutional Holders
52-Week Range
$9.22$22.02
$15.82(52nd percentile)
Volume
Average Daily Volume2.47M
1.50M today vs 2.47M avg(-39%)

30d Avg

2.47M

60d Avg

2.68M

90d Avg

2.74M

Earnings
Dividend History
TTM Yield
7.33%
Paid quarterly
Annual (LTM)
$1.16
Latest
$0.2900
Aug 28, 26
5Y Growth
+4.19%
per year
Compliance Status
Loading compliance data...